Business
The Power Play by The Market Herald Releases New Interviews with Else Nutrition, Silver Bullet Mines, Voyageur Pharmaceuticals, RevoluGROUP and Pelangio Discussing Their Latest News
VANCOUVER, BC / ACCESSWIRE / October 24, 2022 / The Power Play by The Market Herald has anno...
About this update from Silver Bullet Mines Corp
[{"type":"text","content":"The Power Play by The Market Herald Releases New Interviews with Else Nutrition, Silver Bullet Mines, Voyageur Pharmaceuticals, RevoluGROUP and Pelangio Discussing Their Latest NewsVANCOUVER, BC / ACCESSWIRE / October 24, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Else Nutrition, Silver Bullet Mines, Voyageur Pharmaceuticals, RevoluGROUP and Pelangio discussing their latest news.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.Else Nutrition (TSX:BABY) enters Chinese market, details company expansionElse (BABY) has launched in China, the world's largest infant formula market. It opened its flagship store with Baozun on Tmall Global on September 29. The company is also reporting that its Kids Shakes will soon be available in Walmart stores in 35 states across the U.S. Co-Founder and CEO, Hamutal Yitzhak, spoke with Daniella Atkinson about the company's recent milestones.For the full interview with Hamutal Yitzhak and to learn about Else, click here.Silver Bullet Mines (TSXV:SBMI) announces $600,000 financingSilver Bullet (SBMI) seeks to raise up to C$600,000 through a non-brokered private placement. The company will issue up to 3,000,000 units at $0.20 per unit. VP Capital Markets Peter Clausi sat down with Daniella Atkinson to discuss the capital raise.For the full interview with Peter Clausi and to learn about Silver Bullet, click here.Voyageur (TSXV:VM) and Rain Cage Carbon to develop fullerene contrast agentsVoyageur (VM) has signed a memorandum of understanding (MOU) with Rain Cage Carbon to develop radiographic drugs. The companies intend to patent drugs, including iodine, gadolinium and iron oxide-based fullerene contrast agents for magnetic resonance imaging and nuclear imaging. CEO Brent Willis sat down with Daniella Atkinson to discuss fullerenes, their role in radiographic drugs, and the company's development plans moving forward.For the full interview with Brent Willis and to learn about Voyageur, click here.RevoluGROUP Canada (TSXV:REVO) provides corporate and product updatesRevoluGROUP Canada (REVO) announced that RevoluSEND began remittances to Venezuela today. Venezuela is now the 117th RevoluSEND remittance...